Tag Archives: Big Pharma

Sanders Praises $35 Cap on Inhalers Just Six Months After Probe Into ‘Outrageous’ Prices

“Americans who have asthma and COPD should not be forced to pay, in many cases, 10 to 70 times more for the same exact inhalers as patients in Europe and other parts of the world,” said the independent senator from Vermont.

By Jon Queally. Published 6-2-2024 by Common Dreams

Less than six months after launching a probe in the U.S. Senate into “the outrageously high prices” that asthma patients and others across the country pay for inhalers, Sen. Bernie Sanders celebrated the official start of a new program by one of the largest makers in the industry on Saturday to cap out of pocket costs at $35.

Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, said Saturday was “the first day of a new program instituted by the major pharmaceutical company Boehringer Ingelheim, which will allow people with asthma and COPD to purchase brand name inhalers at their local drugstore or pharmacy for only $35 dollars.”

Continue reading →

Critics Say Biden Plan to Cut Drug Costs Too Friendly to Big Pharma

Leave a reply

“Federal agencies have shown themselves reluctant to act against unreasonable prices, and this new proposal may give them permission to continue to do nothing,” said one expert.

By Brett Wilkins. Published 12-7-2023 by Common Dreams

While welcoming the White House’s willingness to tackle pharmaceutical companies’ patent abuse and high prescription drug prices, progressive critics argued Thursday that U.S. President Joe Biden must do more to challenge Big Pharma’s monopoly power.

The White House on Thursday announced “new actions to promote competition in healthcare and support lowering prescription drug costs for American families, including the release of a proposed framework for agencies on the exercise of march-in rights on taxpayer-funded drugs and other inventions.”

Continue reading →

Families Rally for Opioid Accountability as Supreme Court Hears Purdue Case

Leave a reply

“I don’t want their money,” one woman who lost a son to the opioid crisis said of the Sackler family. “I want them in prison.”

By Julia Conley. Published 12-4-2023 by Common Dreams

Family members who lost loved ones to the opioid epidemic rallied at the U.S. Supreme Court on December 4, 2023 to oppose a bankruptcy deal that would allow Purdue Pharma to avoid liability for the deaths of millions of people from opioid use disorder.
(Photo: @aneripattani /Twitter)

At the U.S. Supreme Court on Monday, families whose loved ones are among the tens of thousands of Americans who have died of opioid use disorder each year over the past two decades rallied to push the nine justices to reject a proposed bankruptcy plan that would give the former owners of Purdue Pharma legal immunity—with many joining the U.S. Justice Department in arguing that the company should not be released from accountability for the opioid epidemic.

Purdue Pharma filed for bankruptcy in 2019, as the number of Americans killed by opioids hit 50,000 and the OxyContin manufacturer faced thousands of lawsuits alleging its aggressive marketing of the addictive painkiller had fueled the rising death toll.

Continue reading →

‘For Shame’: Pfizer to Charge $1,390 for Lifesaving Covid Drug That Costs Just $13

Leave a reply

“Pfizer treats Paxlovid like a Prada handbag; a luxury for the few rather than a treatment for the many,” said one consumer advocate.

By Brett Wilkins. Published 10-19-2023 by Common Dreams

U.S. consumer watchdog Public Citizen on Thursday excoriated Pfizer after the pharmaceutical giant announced it would more than double the price of a lifesaving Covid-19 treatment, which will soon sell for an estimated 100 times the cost of production.

Pfizer said Wednesday that it will price its patented Covid treatment nirmatrelvir-ritonavir—sold under the brand name Paxlovid—at $1,390 for a five-day course. Researchers Melissa J. Barber and Dzintars Gotham recently estimated it costs Pfizer $13 to produce five days’ worth of the drug, which is taken in three-pill doses.

Continue reading →

In ‘First Major Blow to Big Pharma,’ Federal Judge Blocks Medicare Drug Price Negotiation Injunction

Leave a reply

The judge said plaintiff the Chamber of Commerce “demonstrated neither a strong likelihood of success nor irreparable harm.”

By Olivia Rosane. Published 9-30-2023 by Common Dreams

A federal judge in Ohio on Friday blocked an attempt by corporate interests to stop Medicare’s historic negotiation of certain drug prices with pharmaceuticals.

Medicare gained the power to negotiate drug prices as part of the Inflation Reduction Act (IRA), but the several industry groups and drug makers have sued to forestall the program, arguing that it is unconstitutional, CNN explained. One of those groups was the U.S. Chamber of Commerce, which filed its lawsuit in June. The Ohio judge Friday rejected its request for a preliminary injunction to block the program before October 1, the date by which pharmaceuticals must agree to negotiate or not.

Continue reading →

Three Years Into Covid Pandemic, World Leaders Say ‘Never Again’ to Vaccine Apartheid

Leave a reply

“These past three years should act as a warning for future pandemics,” said former U.N. Secretary-General Ban Ki-moon. “We need a return to genuine cooperation between nations in our preparation and response to global threats.”

By Brett Wilkins. Published 3–10-2023 by Common Dreams

National COVID 19 Vaccine Introduction Launching Program at Eka Kotebe Hospital Addis Ababa, March 13,2021. Photo: UNICEF Ethiopia/fluckr/CC

Around 200 current and former world leaders, Nobel laureates, health and faith leaders, and activists this week marked the third anniversary of the World Health Organization’s Covid-19 pandemic declaration by taking aim at the “vaccine apartheid” that according to one advocacy group was responsible for one death every 24 seconds during the outbreak’s first year alone.

A letter led by the People’s Vaccine Alliance notes that three years have passed since “the World Health Organization (WHO) first characterized Covid-19 as a pandemic” on March 11, 2020 and implores governments to “never again” allow nationalism and capitalist greed to supersede human needs.” Continue reading →

‘Deeply Sinister’: Emails Reveal Big Pharma Pushed Twitter to Silence Vaccine Equity Voices

Leave a reply

“At a time when online mobilizations were one of the few forms of protest available to the public, Twitter was seemingly asked to shield the powerful from criticism,” said one campaigner. “That should worry all those who care about accountability.”

By Brett Wilkins. Published 1-16-2023 by Common Dreams

lobal Justice Now and The People’s Vaccine projection campaigning for global vaccine equality in London on March 8, 2021. (Photo: Jess Hurd/Global Justice Now via Flickr)

Drugmaker BioNTech and the German government pushed Twitter to “hide” posts by activists calling on Big Pharma to temporarily lift patents on Covid-19 vaccines—a move which would have given people the Global South greater access to the lifesaving inoculations, a report published Monday by The Intercept revealed.

Twitter lobbyist Nina Morschhaeuser “flagged the corporate accounts of Pfizer, BioNTech, Moderna, and AstraZeneca for her colleagues to monitor and shield from activists,” according to The Intercept‘s Lee Fang. An email from Morschhaeuser said the German Federal Office for Information Security also contacted Twitter on behalf of BioNTech, whose spokesperson, Jasmina Alatovic, asked the social media giant to “hide” activist tweets targeting her company’s account for two days. Continue reading →

Pharma Giants to Hike 350+ US Drug Prices in the New Year: Analysis

Leave a reply

“Why? Because they can. Big Pharma does not care about us.”

By Brett Wilkins. Published 12-30-2022 by Common Dreams

Photo: Images Money/flickr/CC

Global pharmaceutical giants plan to hike U.S. prices for hundreds of drugs next month in anticipation of the Biden administration’s Inflation Reduction Act, which will allow Medicare to negotiate the cost of certain drugs starting in 2026, an analysis published Friday revealed.

The analysis, conducted by the healthcare research company 3 Axis Advisors and reported on by Reuters, said that Big Pharma corporations including Pfizer, AstraZeneca PLC, and Sanofi SA are set to raise the list prices—which do not include any rebates—on over 350 drugs early in January. Continue reading →

‘Heartbreaking’ and ‘Pathetic’: US Obstructs Patent Waiver for Covid Tests and Treatments

Leave a reply

“There have been at least 290,000 deaths from Covid-19 since the WTO punted on the question of global access to tests and treatments back in June,” said one advocate. “How many more need to die before the U.S. joins the right side of history?”

By Kenny Stancil. Published 12-6-2022 by Common Dreams

Photo: Amnesty International/CC

Global health campaigners denounced U.S. President Joe Biden’s administration for refusing to support a temporary suspension of patents for Covid-19 tests and treatments this year, a move that further delays the possibility of securing a World Trade Organization intellectual property waiver aimed at increasing access to lifesaving medical tools in developing nations.

In a statement released on Tuesday morning, U.S. Trade Representative Katherine Tai said that “over the past five months, USTR officials held robust and constructive consultations with Congress, government experts, a wide range of stakeholders, multilateral institutions, and WTO members.” Continue reading →

Patients Push Biden HHS to Act as Pharma Firm Charges $190K for Lifesaving Prostate Cancer Drug

Leave a reply

“HHS can clearly insist on limiting the U.S. price of Xtandi to the median price for other large high-income countries,” said advocates, “particularly since the drug has already generated more than $10 billion in sales from Medicare alone based upon these unconscionable pricing disparities.”

By Brett Wilkins Published 11-20-2022 by Common Dreams

Screenshot: GlobalGiving

“Cancer does not wait, nor should cancer patients have to wait for years for their government to act.”

That’s the message patient advocates reiterated in a Friday letter asking the Biden administration to help them secure a lifesaving prostate cancer drug that costs nearly $190,000 per year despite its development being 100% taxpayer-funded.

Last year, prostate cancer patient Eric Sawyer petitioned U.S. Health and Human Services (HHS) Secretary Xavier Becerra to grant march-in rights—under which the government can grant patent licenses to companies other than a drug’s manufacturer—for enzalutamide, which is sold under the brand name Xtandi. Continue reading →

Occupy World Writes

The Movement Continues – Globally

Tag Archives: Big Pharma